refractory Classical Hodgkin's Lymphoma

DBCOND0144296Hemic and Lymphatic DiseasesImmunoproliferative Disorders

refractory Classical Hodgkin's Lymphoma is the indication for 1 drug in DrugBank. It is covered by 5 curated, structured indications.

Also known as
Refractory Classical Hodgkin Lymphoma · Refractory Classic Hodgkin Lymphoma · Classical Hodgkin lymphoma refractory
Classified under
Indicated drugs

Resolves to

Vocabularies
SNOMED CT461311000124107MedDRA10020257UMLSC0855082

What you can answer from here — as of October 23, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
5Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
14Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for refractory Classical Hodgkin's Lymphoma share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In